Recent Articles

Hyperbaric oxygen therapy: Evidence-based uses and unproven claims

Gatorade. Liquid IV. Do you need extra electrolytes?

Sexual violence can cast a long shadow on health

Prostate cancer: Short-course radiation just as effective as longer-term treatments

Eggs, protein, and cholesterol: How to make eggs part of a heart-healthy diet

Can a quick snooze help with energy and focus? The science behind power naps

Autism: The challenges and opportunities of an adult diagnosis

Hospice care: Overview of a compassionate approach to end-of-life care

Foot pain: A look at why your feet might hurt

Matcha: A look at possible health benefits

Ameet Sarpatwari, JD, PhD

Contributing Editor

Ameet Sarpatwari is an Instructor in Medicine at Harvard Medical School and an Associate Epidemiologist at Brigham and Women’s Hospital based in the Program On Regulation, Therapeutics, And Law (PORTAL) within the Division of Pharmacoepidemiology and Pharmacoeconomics. His research draws upon his interdisciplinary training as an epidemiologist and lawyer and focuses on the effects of laws and regulations on therapeutic development, approval, use, and related public health outcomes. Among other projects, he is currently examining the public health implications of variation in state drug product selection laws, the risk of re-identification under HIPAA pathways for data sharing for post-approval drug research, and the comparative safety and effectiveness of biosimilars.